Cohen Says Hydroxychloroquine Studies More Provocative Than Definitive
June 5, 2020
A Bloomberg article recently featured a key study of the malaria drug hydroxychloroquine, for Covid-19 protection, that involved 821 health-care workers, first responders and people living with infected patients. The article reports “half were given hydroxychloroquine for five days, while the other half received a placebo pill that contained the...